176 related articles for article (PubMed ID: 33547792)
1. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
Zager RA; Johnson ACM; Therapeutics R
Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
[TBL] [Abstract][Full Text] [Related]
2. Parenterial iron sucrose-induced renal preconditioning: differential ferritin heavy and light chain expression in plasma, urine, and internal organs.
Johnson AC; Gooley T; Guillem A; Keyser J; Rasmussen H; Singh B; Zager RA
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1563-F1571. PubMed ID: 31608670
[TBL] [Abstract][Full Text] [Related]
3. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
Zager RA; Johnson AC; Frostad KB
Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Molecular Mechanisms of Renal Hepcidin Induction and Protection upon Hemoglobin-Induced Acute Kidney Injury.
Diepeveen LE; Stegemann G; Wiegerinck ET; Roelofs R; Naber M; Lóreal O; Smeets B; Thévenod F; Swinkels DW; van Swelm RPL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163276
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
Aleksunes LM; Goedken MJ; Rockwell CE; Thomale J; Manautou JE; Klaassen CD
J Pharmacol Exp Ther; 2010 Oct; 335(1):2-12. PubMed ID: 20605904
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and consequences of oxidant-induced renal preconditioning: an Nrf2-dependent, P21-independent, anti-senescence pathway.
Johnson ACM; Zager RA
Nephrol Dial Transplant; 2018 Nov; 33(11):1927-1941. PubMed ID: 29522116
[TBL] [Abstract][Full Text] [Related]
7. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
[TBL] [Abstract][Full Text] [Related]
8. The NRF2 stimulating agent, tin protoporphyrin, activates protective cytokine pathways in healthy human subjects and in patients with chronic kidney disease.
Zager RA; Johnson ACM
Physiol Rep; 2020 Sep; 8(18):e14566. PubMed ID: 32940965
[TBL] [Abstract][Full Text] [Related]
9. Acute hepatic ischemic-reperfusion injury induces a renal cortical "stress response," renal "cytoresistance," and an endotoxin hyperresponsive state.
Zager RA; Johnson AC; Frostad KB
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F856-68. PubMed ID: 25080526
[TBL] [Abstract][Full Text] [Related]
10. Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
Johnson ACM; Delrow JJ; Zager RA
Transl Res; 2017 Aug; 186():1-18. PubMed ID: 28586635
[TBL] [Abstract][Full Text] [Related]
11. Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.
Johnson AC; Becker K; Zager RA
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F426-35. PubMed ID: 20504881
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Hepcidin Expression Associates with Injury Independent of Iron.
van Breda GF; Bongartz LG; Zhuang W; van Swelm RP; Pertijs J; Braam B; Cramer MJ; Swinkels DW; Doevendans PA; Verhaar MC; Masereeuw R; Joles JA; Gaillard CA
Am J Nephrol; 2016; 44(5):368-378. PubMed ID: 27771699
[TBL] [Abstract][Full Text] [Related]
13. Renal Handling of Circulating and Renal-Synthesized Hepcidin and Its Protective Effects against Hemoglobin-Mediated Kidney Injury.
van Swelm RP; Wetzels JF; Verweij VG; Laarakkers CM; Pertijs JC; van der Wijst J; Thévenod F; Masereeuw R; Swinkels DW
J Am Soc Nephrol; 2016 Sep; 27(9):2720-32. PubMed ID: 26825531
[TBL] [Abstract][Full Text] [Related]
14.
McLachlan S; Page KE; Lee SM; Loguinov A; Valore E; Hui ST; Jung G; Zhou J; Lusis AJ; Fuqua B; Ganz T; Nemeth E; Vulpe CD
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G511-G523. PubMed ID: 28798083
[TBL] [Abstract][Full Text] [Related]
15. A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.
Zager RA; Johnson ACM; Guillem A; Keyser J; Singh B
Clin J Am Soc Nephrol; 2020 May; 15(5):633-642. PubMed ID: 32291269
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.
Scindia Y; Dey P; Thirunagari A; Liping H; Rosin DL; Floris M; Okusa MD; Swaminathan S
J Am Soc Nephrol; 2015 Nov; 26(11):2800-14. PubMed ID: 25788528
[TBL] [Abstract][Full Text] [Related]
17. Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.
Zager RA
Physiol Rep; 2022 Oct; 10(20):e15507. PubMed ID: 36305701
[TBL] [Abstract][Full Text] [Related]
18. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
[TBL] [Abstract][Full Text] [Related]
19. Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD
Nazari Soltan Ahmad S; Rashtchizadeh N; Argani H; Roshangar L; Ghorbani Haghjo A; Sanajou D; Panah F; Ashrafi Jigheh Z; Dastmalchi S; Mesgari-Abbasi M
Free Radic Res; 2018 Jul; 52(7):808-817. PubMed ID: 29865885
[TBL] [Abstract][Full Text] [Related]
20. Icariin regulates systemic iron metabolism by increasing hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling.
Zhang M; Liu J; Guo W; Liu X; Liu S; Yin H
Int J Mol Med; 2016 May; 37(5):1379-88. PubMed ID: 27035325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
